Akums secures European CEP approval for Cefpodoxime Proxetil, strengthening its global regulatory standing and expanding access to regulated markets, reinforcing India’s growing role in compliant API manufacturing and pharma supply chains.
Intracin Pharma, APVMA approval, and Australia expansion mark a major milestone for the Indian veterinary pharmaceutical company as it prepares to supply veterinary medicines in Australia, one of the world’s most tightly regulated animal healthca...
SII to manufacture Oxford Ebola vaccine with $8.6M CEPI funding as global agencies race to contain Africa outbreak, boosting India’s role in vaccine production.
In an interaction with India Pharma Outlook, Vasishtha Mehta, Founder & MD at Anthem GxP Solutions, highlights how India’s pharmaceutical industry is transitioning from paper-based compliance to digital, data-driven systems powered by AI, MES, and au
China’s biotech boom drives $10.5B Pfizer-Innovent deal, highlighting global shift to innovation while exposing India’s gaps in research, funding, and licensing.
Hikal posts Q4 FY26 profit recovery driven by crop protection growth and cost actions, despite USFDA impact and one-time charges, while maintaining dividend payout.
New clinical review validates capsaicin 0.075% for diabetic neuropathy pain relief, offering targeted, localized therapy with improved patient comfort and safety.
Regeneron’s Hyderabad GCC highlights India’s growing role in global biopharma R&D. The move signals a shift beyond cost arbitrage toward high-value capabilities in AI, clinical trials, and data-driven drug development.
Immuneel Therapeutics CAR T therapy shows two-year remission in aggressive blood cancer, highlighting durable clinical outcomes and improved access to advanced cell therapy in India.
Mental disorders have emerged as the leading cause of disability worldwide, overtaking major illnesses such as cancer and cardiovascular diseases, according to a new global study. The findings have raised serious concerns for India, where...